Biogen offloads nearly $600M in Cambridge real estate — making room for a Broad Institute expansion

The fallout of the Covid-19 pandemic is still playing out more than 2.5 years after it began, and the newest effects impacting the biopharma industry fall directly on real estate. Real estate developer BXP said Wednesday that it acquired a building in Cambridge, MA from Biogen for $592 million. The…

Click here to view original post